Navigating the rapidly changing oncology treatment landscape: how digital tools can help
May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
Specific challenges facing the oncology field
1. Increased competition and evolving standard of care
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Gamification for patient care, medical education, and virtual engagement
“Gamification”–adding game-like elements into non-game or real-world settings–has become a popular concept in the pharmaceutical, healthcare, and event industries. However, it is proving more than a mere buzzword. With diverse…
How to Simplify Genetics & Raise Awareness Around Orphan Diseases
Dr. Gail Ouellette, President and Scientific Director of Regroupement Québécois des Maladies Orphelines (RQMO)/Quebec Coalition of Orphan Diseases and Creator of the “Genetics Simply” website, shares her thoughts on the…
Exploring Digital Health From a Patient Perspective
Tjaša Zajc, MedsClub Community Developer and Communication Specialist at Better and the Founder & Host of the Faces of Digital Health podcast, explores international differences in the speed of digital…
InSite Events™ selected as an honorable mention in Fast Company’s 2021 World Changing Ideas Awards
From a cleaner freight train to an automated beehive, a way to recycle fabric, and other bold, new technologies, the 5th annual awards honor the products, concepts, companies, policies, and…
Nanobiotechnology, Artificial Intelligence, and Virtual Care
Venk Varadan, Co-founder & CEO at Nanowear, explores the use of cloth-based nanosensor technology, AI, and deep-learning-enabled diagnostics for remote monitoring of congestive heart failure, chronic diseases, and COVID-19. We…
Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
Jennifer Cox, Manager, Research Contracts at Ottawa Hospital Research Institute (OHRI), dives into the legal challenges associated with virtual trials, remote monitoring, digitalized patient info, and cross-border collaborations in the…
Top 10 Tips to Increase Engagement During Virtual Events
Natalie Yeadon shares her top tips for making your virtual events engaging and interactive
How Patient Advocacy Can Positively Disrupt Healthcare
Seth Rotberg, Patient Recruitment Manager at WEGO Health & Co-Founder of Our Odyssey, shares his views on how to empower rare disease patients, improve clinical trials, and move towards a…
Leaders in Pharma: Danielle Portnik
In this episode of Impetus Digital’s Leaders in Pharma podcast, I sit down with Danielle Portnik. She is currently the Regional Business Director for International with Ambry Genetics.
Leaders in Pharma: Samir Vattompadam
In the inaugural episode of Impetus Digital’s Leaders in Pharma podcast, I sit down with Samir Vattompadam. Samir is currently Vice President, Program Executive for EQRx.